SK165795A3 - 3-phenylizoquinoline-1(2h)-one derivatives, preparation method and pharmaceutical compounds containing these derivatives - Google Patents
3-phenylizoquinoline-1(2h)-one derivatives, preparation method and pharmaceutical compounds containing these derivatives Download PDFInfo
- Publication number
- SK165795A3 SK165795A3 SK1657-95A SK165795A SK165795A3 SK 165795 A3 SK165795 A3 SK 165795A3 SK 165795 A SK165795 A SK 165795A SK 165795 A3 SK165795 A3 SK 165795A3
- Authority
- SK
- Slovakia
- Prior art keywords
- formula
- methyl
- compound
- compounds
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9415837A FR2728900B1 (fr) | 1994-12-29 | 1994-12-29 | Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK165795A3 true SK165795A3 (en) | 1996-07-03 |
Family
ID=9470390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1657-95A SK165795A3 (en) | 1994-12-29 | 1995-12-28 | 3-phenylizoquinoline-1(2h)-one derivatives, preparation method and pharmaceutical compounds containing these derivatives |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5665733A (de) |
| EP (1) | EP0719764B1 (de) |
| JP (1) | JPH08239365A (de) |
| KR (1) | KR960022472A (de) |
| CN (1) | CN1131150A (de) |
| AR (1) | AR002016A1 (de) |
| AT (1) | ATE172966T1 (de) |
| AU (1) | AU698595B2 (de) |
| BR (1) | BR9506106A (de) |
| CA (1) | CA2166234A1 (de) |
| CO (1) | CO4700298A1 (de) |
| CZ (1) | CZ348995A3 (de) |
| DE (1) | DE69505780D1 (de) |
| FI (1) | FI956298A (de) |
| FR (1) | FR2728900B1 (de) |
| HU (1) | HU215394B (de) |
| IL (1) | IL116590A0 (de) |
| NO (1) | NO955326L (de) |
| NZ (1) | NZ280765A (de) |
| PL (1) | PL312079A1 (de) |
| SK (1) | SK165795A3 (de) |
| ZA (1) | ZA9511046B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2750427B1 (fr) * | 1996-06-28 | 1998-08-07 | Synthelabo | Derives de 1-oxo-1, 2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique |
| FR2772758B1 (fr) * | 1997-12-22 | 2000-02-04 | Synthelabo | Derives de 1-oxo-1,2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique |
| ATE496893T1 (de) * | 2002-12-20 | 2011-02-15 | X Ceptor Therapeutics Inc | Isochinolinonderivate und deren verwendung als medikamente |
| GB0420722D0 (en) * | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
| EP2064185B1 (de) * | 2006-08-10 | 2011-06-08 | Ferrer Internacional, S.A. | 1h-chinolin-4-on-verbindungen mit affinität zum gaba-rezeptor, verfahren, anwendungen und zusammensetzungen |
| EP1886996A1 (de) * | 2006-08-10 | 2008-02-13 | Ferrer Internacional, S.A. | 1H-Chinolin-4-on Verbindungen mit Affinität für den GABA Rezeptor, Prozesse, Verwendungen und Zusammensetzungen |
| EP2387564A1 (de) | 2009-01-15 | 2011-11-23 | Rutgers, The State University of New Jersey | Benzo[c]phenanthridine als antimikrobielle mittel |
| WO2010127307A1 (en) | 2009-04-30 | 2010-11-04 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| FR2956816B1 (fr) * | 2010-03-01 | 2012-05-18 | Univ Joseph Fourier | Utilisation de quinolones pour la preparation de medicaments, nouvelles quinolones et leur procede de synthese |
| WO2011156626A1 (en) | 2010-06-09 | 2011-12-15 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| CA2803890A1 (en) | 2010-06-25 | 2011-12-29 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| US9822108B2 (en) | 2012-01-13 | 2017-11-21 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| EP2828245A1 (de) | 2012-03-21 | 2015-01-28 | Rutgers, The State University of New Jersey | Antimikrobiotika |
| US9458150B2 (en) | 2013-11-08 | 2016-10-04 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| US10513528B2 (en) | 2016-02-25 | 2019-12-24 | Taxis Pharmaceuticals, Inc. | Synthetic processes and intermediates |
| US10774093B2 (en) | 2017-03-30 | 2020-09-15 | Taxis Pharmaceuticals, Inc. | Synthetic processes and synthetic intermediates |
| EP4126858A1 (de) * | 2020-03-26 | 2023-02-08 | Richter Gedeon Nyrt. | Dihydro-2-pyrrolo[3,4-c pyridin-derivate als gabaa a5 rezeptormodulatoren |
| TW202202495A (zh) * | 2020-03-26 | 2022-01-16 | 匈牙利商羅特格登公司 | 作為ｇａｍｍａ－胺基丁酸Ａ受體次單元ａｌｐｈａ ５受體調節劑之㖠啶及吡啶并〔３，４－ｃ〕嗒𠯤衍生物 |
-
1994
- 1994-12-29 FR FR9415837A patent/FR2728900B1/fr not_active Expired - Fee Related
-
1995
- 1995-12-18 DE DE69505780T patent/DE69505780D1/de not_active Expired - Lifetime
- 1995-12-18 AT AT95402842T patent/ATE172966T1/de not_active IP Right Cessation
- 1995-12-18 EP EP95402842A patent/EP0719764B1/de not_active Expired - Lifetime
- 1995-12-21 NZ NZ280765A patent/NZ280765A/en unknown
- 1995-12-27 AR ARP950100767A patent/AR002016A1/es unknown
- 1995-12-27 JP JP7340607A patent/JPH08239365A/ja active Pending
- 1995-12-28 KR KR1019950061341A patent/KR960022472A/ko not_active Application Discontinuation
- 1995-12-28 CZ CZ953489A patent/CZ348995A3/cs unknown
- 1995-12-28 CO CO95062144A patent/CO4700298A1/es unknown
- 1995-12-28 CA CA002166234A patent/CA2166234A1/en not_active Abandoned
- 1995-12-28 CN CN95120638A patent/CN1131150A/zh active Pending
- 1995-12-28 US US08/579,677 patent/US5665733A/en not_active Expired - Fee Related
- 1995-12-28 ZA ZA9511046A patent/ZA9511046B/xx unknown
- 1995-12-28 AU AU40712/95A patent/AU698595B2/en not_active Ceased
- 1995-12-28 FI FI956298A patent/FI956298A/fi not_active Application Discontinuation
- 1995-12-28 PL PL95312079A patent/PL312079A1/xx unknown
- 1995-12-28 SK SK1657-95A patent/SK165795A3/sk unknown
- 1995-12-28 HU HU9503848A patent/HU215394B/hu not_active IP Right Cessation
- 1995-12-28 NO NO955326A patent/NO955326L/no unknown
- 1995-12-28 IL IL11659095A patent/IL116590A0/xx unknown
- 1995-12-28 BR BR9506106A patent/BR9506106A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT74187A (en) | 1996-11-28 |
| FI956298A0 (fi) | 1995-12-28 |
| CN1131150A (zh) | 1996-09-18 |
| KR960022472A (ko) | 1996-07-18 |
| CZ348995A3 (en) | 1996-07-17 |
| AR002016A1 (es) | 1998-01-07 |
| DE69505780D1 (de) | 1998-12-10 |
| CA2166234A1 (en) | 1996-06-30 |
| HU215394B (hu) | 1998-12-28 |
| HU9503848D0 (en) | 1996-02-28 |
| EP0719764A1 (de) | 1996-07-03 |
| NO955326D0 (no) | 1995-12-28 |
| PL312079A1 (en) | 1996-07-08 |
| ZA9511046B (en) | 1996-07-11 |
| FR2728900B1 (fr) | 1997-01-31 |
| FI956298A (fi) | 1996-06-30 |
| FR2728900A1 (fr) | 1996-07-05 |
| JPH08239365A (ja) | 1996-09-17 |
| BR9506106A (pt) | 1997-12-23 |
| AU698595B2 (en) | 1998-11-05 |
| CO4700298A1 (es) | 1998-12-29 |
| US5665733A (en) | 1997-09-09 |
| AU4071295A (en) | 1996-07-04 |
| NZ280765A (en) | 1996-08-27 |
| ATE172966T1 (de) | 1998-11-15 |
| IL116590A0 (en) | 1996-03-31 |
| EP0719764B1 (de) | 1998-11-04 |
| NO955326L (no) | 1996-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK165795A3 (en) | 3-phenylizoquinoline-1(2h)-one derivatives, preparation method and pharmaceutical compounds containing these derivatives | |
| US5965575A (en) | N-aryl piperidine compounds as 5HT1B antagonists | |
| IL148218A (en) | History of phenylpiperazines, method of preparation and pharmaceutical preparations containing them | |
| CZ284256B6 (cs) | Nový způsob výroby formoterolu a příbuzných sloučenin | |
| CZ213995A3 (en) | Novel derivatives of 3-hydroxyanthranilic acid, processes and intermediates of their preparation, novel pharmaceutical preparations and their use | |
| EP2623503B1 (de) | Für die behandlung einer durch tcr-nck-interaktion vermittelten krankheit geeignete chromenderivate | |
| CA2727669C (fr) | Nouveaux derives de (piperazinyl ponte)-1-alcanone et leur utilisation comme inhibiteurs de p75 | |
| FR2601011A1 (fr) | Nouveaux derives tricycliques agonistes des recepteurs cholinergiques et medicaments en contenant | |
| NO173010B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt sulfonanilid | |
| SK281867B6 (sk) | Deriváty 3,3a,4,5-tetrahydro-1h-oxazolo[3,4-a]chinolin-1-ónu, spôsob ich prípravy, liečivo a farmaceutický prostriedok obsahujúce tieto deriváty | |
| SK165895A3 (en) | Derivatives of 8-oxo-5,8-dihydro-6h-di-benzo£a,g|quinolizine-13-propanoic acid, their preparation method and a medicine and pharmaceutical compounds containing these derivatives | |
| WO1987002035A1 (en) | Fused cycloaliphatic aminoalcohols | |
| EP0170549B1 (de) | 4,5,6,7-Tetrahydrofuro- oder 1H-Pyrrolo [2,3-c]pyridinderivate, ihre Herstellung und therapeutische Verwendung | |
| JPS6147487A (ja) | オクタヒドロ‐オキサゾロ［４，５‐ｇ］キノリン | |
| JP6808088B2 (ja) | 純粋な５−ｈｔ６受容体アンタゴニストとしてのフルオロピペリジン化合物 | |
| JPH04346986A (ja) | トリチウム標識化されたキサンチン誘導体 | |
| JPH05505801A (ja) | 不飽和ｎ―ベンズオキサジアゾロピラニルラクタム、その製造及び使用 | |
| CN116199682A (zh) | 一种苯基噻唑基苯甲酰胺类化合物及其应用 | |
| FR2772760A1 (fr) | Derives de 3-oxazol-5-yl-1-oxo-1,2-dihydroisoquinoleine-4- propanamide, leur preparation et leur application en therapeutique | |
| JPH0296579A (ja) | アルカロイド化合物、薬剤組成物及びその使用方法 | |
| JPS62142173A (ja) | １，５−ベンゾオキサチエピン誘導体 | |
| FR2772758A1 (fr) | Derives de 1-oxo-1,2-dihydroisoquinoleine-4-propanamide, leur preparation et leur application en therapeutique | |
| JPH03118361A (ja) | ピロリジン誘導体 | |
| JP2002284769A (ja) | 新規なピリミジン誘導体 |